Ad is loading...
FSSNX
Price
$30.08
Change
+$0.54 (+1.83%)
Updated
Nov 22 closing price
THBVX
Price
$15.89
Change
+$0.33 (+2.12%)
Updated
Nov 22 closing price
Ad is loading...

FSSNX vs THBVX

Header iconFSSNX vs THBVX Comparison
Open Charts FSSNX vs THBVXBanner chart's image
Fidelity Small Cap Index
Price$30.08
Change+$0.54 (+1.83%)
VolumeN/A
CapitalizationN/A
Victory THB US Small Opportunities A
Price$15.89
Change+$0.33 (+2.12%)
VolumeN/A
CapitalizationN/A
FSSNX vs THBVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSSNX vs. THBVX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSSNX is a Buy and THBVX is a Buy.

FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 26.9B vs. THBVX (10.1M). FSSNX pays higher dividends than THBVX: FSSNX (1.36) vs THBVX (0.00). FSSNX was incepted earlier than THBVX: FSSNX (13 years) vs THBVX (13 years). THBVX is a more actively managed with annual turnover of: 83.00 vs. FSSNX (9.00). FSSNX has a lower initial minimum investment than THBVX: FSSNX (0) vs THBVX (2500). FSSNX annual gain was more profitable for investors over the last year : 36.08 vs. THBVX (-1.30). FSSNX return over 5 years is better than : 54.79 vs. THBVX (4.61).
FSSNXTHBVXFSSNX / THBVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years13 years-
Gain YTD20.28911.823172%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets26.9B10.1M266,337%
Annual Yield % from dividends1.360.00-
Returns for 1 year36.08-1.30-2,766%
Returns for 3 years5.63-35.98-16%
Returns for 5 years54.794.611,189%
Returns for 10 years94.2811.20842%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPTI0.850.07
+8.67%
Karyopharm Therapeutics
PTPI0.270.01
+5.02%
Petros Pharmaceuticals
LGND119.192.64
+2.27%
Ligand Pharmaceuticals
TXO18.240.23
+1.28%
TXO Partners LP
RVMD56.75-0.03
-0.05%
Revolution Medicines